ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Condition:   Nasopharyngeal Neoplasms
Interventions:   Drug: Apatinib;   Drug: Placebo
Sponsors:   Sun Yat-sen University;   First People's Hospital of Foshan;   Guilin Medical University, China
Not yet recruiting - verified August 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/2bJdigF
via IFTTT